04.01.16
The launch of Probi Järn marks the beginning of products based on the Probi FerroSorb platform. Probi Järn was launched in Sweden by Probi’s partner Bringwell, market leader in probiotic supplements. Probi Järn was launched in February in pharmacies in Sweden and is the latest addition to Bringwell’s probiotic product range. Bringwell has a 52% market share of the probiotic supplement market in Sweden and the existing range includes products based on Probi’s platforms Probi Digestis (gastro health) and Probi Defendum (immune health). The launch of Probi Järn will expand the company’s probiotic offerings, reaching new target groups and strengthening Bringwell´s position in the market.
Probi Järn is a dietary supplement in the form of vegetable capsules containing a combination of the clinically documented lactic acid bacteria LP299V, vitamin C, folic acid and a carefully balanced amount of iron. One capsule daily together with the main meal will help meet daily iron requirements, while minimizing the amount of unabsorbed iron in the intestines. Unabsorbed iron in the intestine is associated with strong digestive discomfort.
Probi Järn is targeting women at risk of iron deficiency. According to WHO, about 20–30% of women of childbearing age suffer from iron deficiency with symptoms such as fatigue, shortness of breath, poor immune function and impaired cognition.
“This launch is the result of Probi’s efforts to offer the market continued development in the growing category of probiotics. Probi has long experience in probiotic research and provides scientifically proven products without compromise” said Johan Wahlqvist, director of marketing & sales consumer healthcare at Probi.
Probi FerroSorb is well documented through five clinical trials showing a significant increase of iron absorption from a meal. The consumer benefit of this research is an increased iron uptake while maintaining a well-functioning digestive system. By increasing the uptake— not only the intake—Probi FerroSorb offers a clinically documented probiotic iron absorption concept, a completely new way of preventing iron deficiency.
Probi Järn is a dietary supplement in the form of vegetable capsules containing a combination of the clinically documented lactic acid bacteria LP299V, vitamin C, folic acid and a carefully balanced amount of iron. One capsule daily together with the main meal will help meet daily iron requirements, while minimizing the amount of unabsorbed iron in the intestines. Unabsorbed iron in the intestine is associated with strong digestive discomfort.
Probi Järn is targeting women at risk of iron deficiency. According to WHO, about 20–30% of women of childbearing age suffer from iron deficiency with symptoms such as fatigue, shortness of breath, poor immune function and impaired cognition.
“This launch is the result of Probi’s efforts to offer the market continued development in the growing category of probiotics. Probi has long experience in probiotic research and provides scientifically proven products without compromise” said Johan Wahlqvist, director of marketing & sales consumer healthcare at Probi.
Probi FerroSorb is well documented through five clinical trials showing a significant increase of iron absorption from a meal. The consumer benefit of this research is an increased iron uptake while maintaining a well-functioning digestive system. By increasing the uptake— not only the intake—Probi FerroSorb offers a clinically documented probiotic iron absorption concept, a completely new way of preventing iron deficiency.
